Nebulized fentanyl for refractory dyspnea secondary to chronic obstructive pulmonary disease (COPD): A case report

We present a case where we evaluated the effectiveness of nebulized fentanyl in the treatment of refractive dyspnea in a patient with chronic obstructive pulmonary disease (COPD) with major complications and comorbidities. Nebulized fentanyl was used to successfully decrease the subjective symptoms...

Descripción completa

Detalles Bibliográficos
Autores principales: Hildreth, Leah, Pett, Danielle, Higgins, Elizabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596332/
https://www.ncbi.nlm.nih.gov/pubmed/33145156
http://dx.doi.org/10.1016/j.rmcr.2020.101251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596332/
https://www.ncbi.nlm.nih.gov/pubmed/33145156
http://dx.doi.org/10.1016/j.rmcr.2020.101251

Ejemplares similares